Gene · 54890
NIH grants903
NIH grants whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 903
Download this page as JSON| Grant | Title | ALKBH5 papers | Newest fiscal year |
|---|---|---|---|
| R01CA259576 | The role of YTHDC1 in normal and malignant hematopoiesis | 2 | 2025 |
| R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 2 | 2025 |
| R01CA266659 | The Novel Role and Mechanism of RBM33 in Leukemogenesis | 2 | 2025 |
| R01CA268634 | Metabolic Regulation of Glioblastoma Epitranscriptomics | 2 | 2025 |
| R01CA291826 | Molecular subtyping of brain tumors using a blood-based multiplexed assay | 2 | 2025 |
| R01DK129489 | The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic stability in HSPCs | 2 | 2025 |
| R01ES031511 | Systems-wide analysis of oxidative stress-responsive m6A epitranscriptome | 2 | 2025 |
| R01ES033197 | METTL3 in chromium-induced angiogenesis and carcinogenesis | 2 | 2025 |
| R01GM058843 | Mass Spectrometry of Modified RNAs | 2 | 2025 |
| R01GM101316 | Functions of mRNA Pseudouridylation | 2 | 2025 |
| R01GM126553 | New directions in single cell genomics method development | 2 | 2025 |
| R01HL157539 | Role of the TET1 short isoform in MDS development and maintenance | 2 | 2025 |
| R35GM131858 | Interrogating Complex Methylome Network with Integrated Chemical Biology Tools | 2 | 2025 |
| R35GM133488 | Atomic-level characterization of self-regulatory mechanisms in large multidomain enzymes | 2 | 2025 |
| R35NS111631 | New mechanisms and technologies for understanding post-transcriptional gene regulation in neurons | 2 | 2025 |
| R37CA252305 | Regulation of tumor suppression by alpha-ketoglutarate | 2 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 2 | 2025 |
| T32AI007647 | Training Program in Mechanisms of Virus-Host Interactions | 2 | 2025 |
| T32CA009056 | Tumor Cell Biology Training Program | 2 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/grants?page=3